Scope 3 and the chemical industry: a challenge with solutions
4 March 2026
No Comments
Increasing demands for transparency on Scope 3 emissions can be daunting – but it
Archives: Articles
Lyophilization in Sterile Pharmaceutical Manufacturing: Regulatory Perspectives and Operational Considerations under EU Annex-1 (2022)
4 March 2026
No Comments
Introduction Sterile pharmaceutical products are governed by stringent Good Manufacturing Practice (GMP) regulations
From digital islands to integrated ecosystems: Envisioning the future of biopharma labs with digital twins
4 March 2026
No Comments
Introduction Biopharmaceutical manufacturing labs have steadily progressed from manual, paper-based environments to semi-automated
Accelerating the bioconjugate CMC journey from early discovery to the clinic
4 March 2026
No Comments
Introduction The pre-clinical development phase of a pharmaceutical drug candidate relies heavily on the
Overview of 2025 year
4 March 2026
No Comments
Over the past 15 years, the global pharmaceutical market has experienced remarkable growth, driven
Angelini Pharma – High-Potent API: strategy and legacy
4 March 2026
No Comments
From APIs to HPAPIs: A Strategic Evolution The pharmaceutical industry is undergoing a
What does agentic AI mean for pharma operations?
3 March 2026
No Comments
AI has already found its place in late-stage pharma R&D operations, as both a
2026 predictions: what are the operational priorities for late-stage pharma R&D?
3 March 2026
No Comments
It may look as though pharma companies are spinning plates, but when it comes
Sustainable Medicines Manufacturing
3 March 2026
No Comments
Global pharmaceutical supply chains are under unprecedented strain. Recent events such as the COVID-19
Panel Discussion on Biotech-CDMO Collaboration
29 January 2026
No Comments
COMMENTARY ARTICLE Beyond partnerships: redefining cdmo-biotech collaboration in the age of complexity Operational Chemistry: